QLESP Block Versus Periarticular Infiltration for Postoperative Analgesia in Hip Surgery

NACompletedINTERVENTIONAL

Enrollment

Participants

Timeline

Start Date

November 18, 2024

Primary Completion Date

September 5, 2025

Study Completion Date

September 5, 2025

Conditions

Regional Anaesthesia

Interventions

DRUG

ropivacaine

Ropivacaine 200 mg diluted to 50 mL

Trial Locations (1)

Union Hospital, Tongji Medical College, Huazhong University of Science and Technology, Wuhan

All Listed Sponsors

lead

Huazhong University of Science and Technology

OTHER

NCT06688136 - QLESP Block Versus Periarticular Infiltration for Postoperative Analgesia in Hip Surgery | Biotech Hunter | Biotech Hunter